Children's Medical Center Corporation;President and Fellows of Harvard College
发明人:
Takao K. Hensch
申请号：
US15160772
公开号：
US20170105980A1
申请日:
2016.05.20
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides methods and compositions for treating subjects suffering from a disorder associated with a nicotinic acetylcholine receptor (nAChR), methods for treating a subject having a disorder that would benefit from an increase in neural plasticity, and methods for modulating the plasticity of the primary visual cortex in subjects by modulating the expression, stability, and/or activity of Lynx1.
